ANDA 72296, held by Quantum Pharmics. Oxybutynin Chloride.
As of Nov 15, 2026, ANDA 72296 (Oxybutynin Chloride), held by Quantum Pharmics, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Oxybutynin Chloride5MG ยท tablet;oral | Oxybutynin Chloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
